ADDED
ABA means applied behavioral analysis, a type of therapy that focuses on improving specific behaviors; ABI/TBI means acquired/traumatic brain injury; ACO means accountable care organization; Behavioral patients and populations mean individuals with intellectual and developmental disabilities including mental illness; BrightSpring, BrightSpring Health Services, Company, we, us, and our refer to BrightSpring Health Services, Inc.
A performance measure over 80% is considered compliant under our contracts with a payor; neuro patients and populations mean individuals who have acquired a traumatic brain injury, spinal cord injury, pediatric autism, or other neurological condition; NPS represents Net Promoter Score, which is a metric used to gauge patient satisfaction based on how likely a patient or physician would be to recommend a company to a friend or colleague.
Americans with five or more chronic conditions make up over 12% of the population and account for 41% of total health care spending, on average spending 14 times more on health services than those without chronic conditions.
Combined, our daily pharmacy and provider services are delivered from and to approximately 7,700 office, clinic, and customer locations across the country, with over 465,000 patients serviced at any one time, including approximately 330,000 patients served in their homes at any one time.
The Company filled over 43 million prescriptions in 2025 from over 175 pharmacies across all 50 states, with services delivered to approximately 6,600 customer locations, approximately 73,000 individual or group homes, and over 410,000 patients, all through over 4,500 unique customer and payor contracts.
Infusion and Specialty Pharmacy prescriptions and Home and Community Pharmacy prescriptions have grown at more than 27% and 3%, respectively, from December 2024 to December 2025.
We deliver on our goals with 99.99% order accuracy and 99.34% order completeness.
We currently have 149 limited distribution oncology drugs in the market with an additional 18 still to launch.
There are 4 exclusive and 16 ultra-narrow drugs with limited pharmacy access.
Following the Community Living divestiture, these services consist of clinical and supportive care to approximately 16,000 Senior and Specialty populations today, with both census for Home Health Care services specifically, and rehab hours served, having grown approximately 9% and 12% from December 2024 to December 2025, respectively.
REMOVED
and its subsidiaries in March 2019; BrightSpring, BrightSpring Health Services, Company, we, us, and our refer to BrightSpring Health Services, Inc.
A designation of Promoter is assigned to respondents who provide a score of 9 or 10, a designation of Passive is assigned to respondents who provide a score of 7 or 8, and a designation of Detractor is assigned to respondents who provide a score of 0 to 6.
Any forward-looking statement made by us in this Annual Report on Form 10-K speaks only as of the date of this Annual Report on Form 10-K and are expressly qualified in their entirety by the cautionary statements included in this Annual Report on Form 10-K.
Americans with five or more chronic conditions make up over 10% of the population and account for 40% of total health care spending, on average spending 10 times more on health services than those without chronic conditions.
Our complex Behavioral clients, often with three or more comorbidities and requiring eight or more medications, are still able to spend 359 days a year at home on average.
Combined, our daily pharmacy and provider services are delivered from and to approximately 11,300 office, clinic, and customer locations across the country, with over 450,000 patients serviced at any one time, including approximately 300,000 patients served in their homes at any one time.
The Company filled over 41 million prescriptions in 2024 from over 180 pharmacies across all 50 states, with services delivered to approximately 7,100 customer locations, more than 60,000 individual or group homes, and over 400,000 patients, all through over 4,700 unique customer and payor contracts.
Infusion and Specialty Pharmacy prescriptions and Home and Community Pharmacy prescriptions have grown at more than 22% and 11%, respectively, from December 2023 to December 2024.
We deliver on our goals with 99.99% order accuracy and 98.63% order completeness.
We currently have 125 limited distribution oncology drugs in the market with an additional 18 in the pipeline still to launch, including 4 exclusive and 14 ultra-narrow drugs with limited pharmacy access.